tiprankstipranks
Portage Biotech (PRTG)
:PRTG
US Market

Portage Biotech Inc (PRTG) Financial Statements

Compare
88 Followers

Portage Biotech Inc Financial Overview

Portage Biotech Inc's market cap is currently $5.26M. The company's EPS TTM is $-65.686; its P/E ratio is ―; Portage Biotech Inc is scheduled to report earnings on February 26, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Mar 23Mar 22Mar 21Mar 20
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ -54.00K-$ 0.00$ 0.00$ 0.00
Operating Income$ -18.25M$ -16.57M$ -15.59M$ -12.44M$ -5.98M
EBITDA$ -18.20M$ -15.78M$ 0.00$ 0.00$ 0.00
Net Income$ -75.34M$ -104.61M$ -19.17M$ -17.19M$ -7.25M
Balance Sheet
Cash & Short-Term Investments$ 5.03M$ 10.54M$ 23.35M$ 2.77M$ 3.22M
Total Assets$ 7.78M$ 99.13M$ 194.66M$ 174.86M$ 173.17M
Total Debt$ 47.00K$ 0.00$ 0.00$ 150.00K$ 3.66M
Net Debt$ -4.98M$ -10.54M$ -23.35M$ -2.62M$ 509.00K
Total Liabilities$ 4.45M$ 23.73M$ 29.23M$ 27.26M$ 27.53M
Stockholders' Equity$ 4.02M$ 76.05M$ 121.20M$ 101.45M$ 96.53M
Cash Flow
Free Cash Flow$ -14.30M$ -12.08M$ -6.76M$ -3.28M$ -3.71M
Operating Cash Flow$ -14.30M$ -12.07M$ -6.76M$ -4.28M$ -3.71M
Investing Cash Flow$ 2.81M$ -617.00K$ 0.00$ -860.00K$ 0.00
Financing Cash Flow$ 5.97M$ -117.00K$ 27.35M$ 4.76M$ 700.00K
Currency in USD

Portage Biotech Inc Earnings and Revenue History

Portage Biotech Inc Debt to Assets

Portage Biotech Inc Cash Flow

Portage Biotech Inc Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis